| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.78B | 7.53B | 7.68B | 7.42B | 7.54B | 7.43B |
| Gross Profit | 2.56B | 2.70B | 2.34B | 2.15B | 2.24B | 2.09B |
| EBITDA | 661.00M | 742.00M | 514.00M | 316.00M | 458.00M | 355.00M |
| Net Income | 457.00M | 473.00M | 358.00M | 125.00M | 369.00M | 247.00M |
Balance Sheet | ||||||
| Total Assets | 5.17B | 5.41B | 5.75B | 5.43B | 6.06B | 6.25B |
| Cash, Cash Equivalents and Short-Term Investments | 3.22B | 3.23B | 3.69B | 3.44B | 3.73B | 3.98B |
| Total Debt | 537.00M | 587.00M | 674.00M | 562.00M | 849.00M | 937.00M |
| Total Liabilities | 1.29B | 1.52B | 1.54B | 1.34B | 1.67B | 1.78B |
| Stockholders Equity | 3.88B | 3.89B | 4.20B | 4.08B | 4.39B | 4.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 657.00M | 485.00M | 234.00M | 329.00M | 344.00M |
| Operating Cash Flow | 0.00 | 673.00M | 510.00M | 260.00M | 372.00M | 359.00M |
| Investing Cash Flow | 0.00 | -273.00M | -132.00M | 156.00M | -86.00M | 224.00M |
| Financing Cash Flow | 0.00 | -868.00M | -121.00M | -719.00M | -546.00M | -419.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥8.59B | 6.67 | ― | 1.24% | 16.81% | 63.22% | |
78 Outperform | ¥5.42B | 12.51 | ― | 4.65% | -1.93% | 44.83% | |
78 Outperform | ¥15.05B | 3.90 | ― | 2.46% | 23.83% | 89.77% | |
75 Outperform | ¥11.89B | 11.62 | ― | 1.27% | 10.46% | 53.77% | |
66 Neutral | ¥8.49B | 12.89 | ― | 2.61% | 11.54% | 222.33% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
54 Neutral | ¥15.48B | -10.28 | ― | 7.85% | -38.96% | -127.02% |